27 Need to revise pharma syllabus -An evergreen topic to keep every body green-contd from 26.
Extract from the link;http://www.pci.nic.in/ SCHEME FOR OBTAINING PERMISSION OF PHARMACY COUNCIL OF INDIA TO START PHARM.D. OR PHARM.D. AND PHARM.D. (POST BACCALUERATE) PROGRAMME All applications under this scheme be submitted to the Secretary, Pharmacy Council of India, before the prescribed date mentioned in the schedule 1. Eligibility Criteria: The following organizations shall be eligible to apply in the SIF for permission to start the Pharm.D., programme/s namely: a. A State Government / Union Territory b. A University c. A Registered Society under the Societies Registration Act 2. Qualifying Criteria: Conditions to be fullfilled by person, institution, society or University to qualify to apply to PCI for permission to start Pharm.D. programme/s: a. The consent of Affiliation for the proposed Pharm.D. programme/s by the applicant from a University. b. No admission shall be made by the applicant to the proposed Pharm.D. programme/s without prior permission of the PCI. c. The applicant shall provide necessary additional infrastructural facilities as prescribed by the PCI under "Appendix - B" of Pharm.D. regulations for the starting of Pharm.D. programme/s. Opening of the Pharm.D. programme/s in a hired or rented building shall not be permitted. d. The applicant should have been approved under section 12 of the Pharmacy Act 1948 for the conduct of B.Pharm course. e. The applicant shall provide 300 bed hospital facility as prescribed under regulation 2) of "Appendix - B" of Pharm.D. regulations. xxxxxxxxxxxxxx My comment; The eligibility criteria is silent on the quality of the teaching faculty. With due regards and respect, I strongly feel that faculty qualification should be revised and updated, The institution / PCI should not hesitate to appoint / hire the services of the professionals from the field, wherever required. The 'Ego' and claim that I can teach every aspect of the topic with the desired orientation is very bad and detrimental to the students. When I was a student, one Mr Ganapati a B Pharm was a better knowledgeable teacher than the M Pharms and PhDs we had. Lets be honest and be more practical and also be responsible to the future generation. Untill, we have our own inhouse qualified staff with field experience , lets hire the professionals from the field, even though they may be less qualified wrt the University degree. But their knowledge and skill is invaluable. I find certain ambiguities like; Pharmacoepidemiology; I do not understand Why it is made 'pharmaco' unnecessarily. Are we studying the epidemiology of the drug or the diseases? If we are studying the epidemiology of the drug (which is unheard of) - it is Ok to call it pharmaco-.... If we are studying the diseases it should be called Epidemiology as commonly being called. Similarly, epidemiology and economics being combined is irrational. Pharma-economics is best taught under hospital pharmacy / clinical pharmacy as it is applicable to all categroy of treatment. Pharm D graduates unless they are also made to fit into the Aurvedic mold, the burden of pharmacognosy could have been be reduced. This will only diffuse the focus on the much needed topics I am sure they cannot venture into the Ayurvedic hospitals. Pharmaceutics Medicinal Biochemistry Pharmacotherapeutics-I Pharmacotherapeutics-II Pharmacotherapeutics-III Biopharmaceutics & Pharmacokinetics Clinical Pharmacokinetics & Pharmacotherapeutic Drug Monitoring - All these subjects with jugglery of words and terminology appear to be overlapping and one may lose grip on scope and limitations if they are not taught by people with extraordinary expertise having clear vision of the scenario. -pharmaceutics in the I year and Biopharmaceutics in the IV year is too wide apart for the student to comprehend. well, have we prepared the field tp absorb the the PharmD graduates when they come out with a degree? If I am wrong in my opinion pl correct me. If convinced I gracefully accept.